Diferencia entre revisiones de «High altitude cerebral edema»
(ref added) |
Sin resumen de edición |
||
| Línea 31: | Línea 31: | ||
==Source== | ==Source== | ||
Tintinalli | *Tintinalli | ||
Cone David, et al. Emergency Medical Services: Clinical Practice and Systems Oversight, 2 Volume Set. John Wiley & Sons, Dec 30, 2014. | *Cone David, et al. Emergency Medical Services: Clinical Practice and Systems Oversight, 2 Volume Set. John Wiley & Sons, Dec 30, 2014. | ||
[[Category:Environ]] | [[Category:Environ]] | ||
Revisión del 02:33 2 mar 2015
Background
- Also known as HACE
- Progressive neurologic deterioration in someone with AMS or HAPE (due to incr ICP)
- Almost never occurs at <8000ft
Clinical Features
- Altered mental status, ataxia, gait disturbance, stupor (most sensitive findings)
- Progresses to coma if untreated
- Headache, nausea, and vomiting are not always present
- Focal neuro deficits may be seen (3rd/6th CN palsies)
- Seizures are rare
Differential Diagnosis
High Altitude Illnesses
- Acute mountain sickness
- Chronic mountain sickness
- High altitude cerebral edema
- High altitude pulmonary edema
- High altitude peripheral edema
- High altitude retinopathy
- High altitude pharyngitis and bronchitis
- Ultraviolet keratitis
- Dehydration
- Exhaustion
- Hypoglycemia
- Hypothermia
- Hyponatremia
Treatment
- Immediate descent is the treatment of choice
- If descent not possible use combination of:
- Supplemental O2 (goal SpO2 90%)
- Dexamethasone 8mg initially, then 4mg q6hr
- Acetazolamide 250 mg BID (better as ppx)
- Hyperbaric bag if available
See Also
Source
- Tintinalli
- Cone David, et al. Emergency Medical Services: Clinical Practice and Systems Oversight, 2 Volume Set. John Wiley & Sons, Dec 30, 2014.
